Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial (Q37240710)
Jump to navigation
Jump to search
scientific article published on 13 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial |
scientific article published on 13 April 2009 |
Statements
1 reference
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial (English)
1 reference
Mitch Dowsett
1 reference
Giuseppe Viale
1 reference
Marion Procter
1 reference
Worta McCaskill-Stevens
1 reference
Urania Dafni
1 reference
Josef Rueschoff
1 reference
Bruce Jordan
1 reference
Stella Dolci
1 reference
Mark Abramovitz
1 reference
Oliver Stoss
1 reference
Richard D Gelber
1 reference
Brian Leyland-Jones
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference